Table 1.
Articles using plasma membrane anchored chimeric proteins to study the function of the COOH-terminal tail of Polycystin 1
Reference | Model system | Findings |
---|---|---|
Sutters 200117 | M1 cells; dexamethasone inducible sIg7-PC1-193 | sIg7-PC1-193 transforms the response to cAMP from growth inhibition to growth stimulation. |
Vandorpe 200218 | Xenopus oocytes and HEK cells; CD16.7-PC1(CTT constructs) | CD16.7-PKD1(1–226), (115–226), (115–203) or (115–189), but not CD16.7-PKD1(1–92), (1–115), (1–155) or CD16.7 (control) up-regulate a nonselective Ca2+-permeable cation conductance. |
Aguiari 200319 | HEK-293 and HeLa cells; Trk-PC1(CTT constructs) | Trk-PC1-1-226 or 26-226 enhance ATP-evoked (HEK) and histamine-evoked (HeLA) cytosolic Ca2+ transients (upregulation of PC2 or other intracellular cation channel activity?). |
Hooper 200321 | M1 cells; dexamethasone inducible sIg7-PC1-193 | sIg7-PC1-193 enhances ATP induced, but not forskolin induced, chloride secretory currents. |
Wildman 200320 | M1 cells; dexamethasone inducible sIg7-PC1-193 | sIg7-PC1-193 prolongs the decay phase of ATP induced Ca2+ transients and the duration of ATP stimulated Cl-conductance. |
Puri 200422 | HEK cells; sIg7-PC1(CTT constructs) | PC1 constructs containing the heterotrimeric G protein binding and activation domain activate Gαq and PLC, releasing of Ca2+ from intracellular stores, activating store-operated Ca2+ entry, and activating calcineurin and NFAT. |
Manzati 200523 | HEK-293 cells; Trk-PC1(26–226) | Trk-PC1(26–226) expressing cells have higher basal Ca2+ concentration and 1% FBS or ATP induced Ca2+ transients and proliferative responses. |
Xu 200724 | NK cells; CD16.7-PC1(115–226). | CD16.7-PKD1(115–226) accelerates the decay of flow-induced Ca2+ transients. |